World Class Opportunities for Clinical Research in Region Västra Götaland, Sweden
(On the pic: Kaj Stenlöf, Gothia Forum’s Executive Director)
Västra Götaland tops the ranking in Europe when it comes to trade and industry’s investment in research and technology development and employs about 20 % of the nation’s life science employees. A coordinated effort in clinical research has been made in establishing Gothia Forum offering world class research infrastructure and a successful model for cooperation.
– We are bringing hospitals, academia and life science industry together to ensure efficient cooperation and communication. We offer easy access to all sites/clinics, experts and research support available in this region, says Kaj Stenlöf, Gothia Forum’s Executive Director.
Sweden maintains a strong international position in clinical research, it is the world’s 12th largest producer of research results and placed 6th in the analysis of the most cited publications.Region Västra Götaland is the second largest county in Sweden located on the west coast. This area is home to one of Europe’s largest university hospitals, to cutting-edge research in biomedicine and the natural sciences, to a strong research-based biomaterials industry, to AstraZeneca, a “mega-site” within global pharmaceutical development, and the list goes on.
Gothia Forum has received both national and international attention as a successful model for cooperation. Gothia Forum serves as a meeting place and offer support for researchers and businesses, regardless of size, in the life science sector. Gothia Forum can help with anything from large clinical studies to testing, research projects and quality training and was formed through a unique collaboration among the pharmaceutical industry, Chalmers University of Technology, the Sahlgrenska Academy, the Sahlgrenska University Hospital, and Region Västra Götaland.
It is widely known that Swedish clinical data is of high quality, the result of both strong clinical trials know-how and a cultural trait of doing things in orderly manner. The region has a special registry competence center which can help create new quality registries for quality assessments and improvements of healthcare.
One of Sweden’s rare Phase I units is located in this region. The Clinical Trial Center, CTC, is an integrated part of the R&D organization at Sahlgrenska University hospital and is a service organization for all specialists and researchers at the hospital and the Sahlgrenska Academy. CTC is approved for any trial from First-in-Man to Phase IV studies and offers a highly skilled resource. Several large pharmaceutical research companies have agreements with CTC and work closely to guarantee an efficient and functional development of the center. It is a preferred site for multiple drug and CRO companies.
Contact information: www.gothiaforum.com
